Psychosocial factors in psoriasis: A pilot study;Psychosoziale belastungen bei psoriasis vulgaris: Eine pilotstudie

Hautarzt

Volumn 58, Issue 11, 2007, Pages 959-965

  Bahmer, J A ^a   Petermann, F ^a   Kuhl, J ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Cognitive styles; Coping; Psoriasis; Psychosocial factors; Rehabilitation

Indexed keywords

CYCLOSPORIN; METHOTREXATE;

ANGER; ARTICLE; CLINICAL ARTICLE; COPING BEHAVIOR; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; MENTAL STRESS; PATIENT COMPLIANCE; PERSONALITY; PILOT STUDY; PSORIASIS; PSYCHIATRY; PSYCHOSOMATIC DISORDER; REHABILITATION CARE; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; CHRONIC DISEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HOSPITALIZATION; HUMANS; INTERPERSONAL RELATIONS; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; PSORIASIS; PSYCHOMETRICS; PSYCHOTHERAPY; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 36048938754     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1371-4     Document Type: Article

References (43)

1. Abel E, DiCicco L, Orenberg E et al. (1986) Drugs in exacerbation of psoriasis. J Am Acad Dermatol 15: 1007-1022
2. Bahmer JA (2005) Chronische Dermatosen und Persö nlichkeitsstrukturen. Dt Derm 5: 317-319
3. Bahmer JA (2006) Diagnostik und Förderung Integrativer Kompetenz bei Psoriasis - Entwicklung, Durchführung und Evaluation einer persönlichkeitsadaptierten, sekundärpräventiven Patientenschulung. Shaker, Aachen
4. Bahmer JA, Kuhl J Bahmer FA (2007) How do personality systems interact in patients suffering from psoriasis, atopic dermatitis and urticaria? Acta Derm Venereol (in press)
5. Barker JN (2001) Genetic aspects of psoriasis. Clin Exp Derm 26: 321-325
6. Bhosle M, Kulkarni A, Feldman SR, Balkrishnan R (2006) Quality of life in patients with psoriasis. Health Quality Life Outcomes 4: 35-42
7. Bonnekoh B, Schmid-Ott G, Herold S et al. (2006) Interdisziplinäre Psoriasisschulung in Blockform. Ein Halbjahres-Follow-Up. Hautarzt 57: 917-921
8. Bos WE, Thio HB, Neumann HA et al. (2006) New systemic treatments for psoriasis: Etanercept, Infliximab, Adalimumab, Efalizumab und Alefacept. Ned Tijdschr Geneeskd 150: 1065-1070
9. Chaput JC, Paynard T, Noveau S et al. (1985) Psoriasis, alcohol and liver disease. BMJ 291: 25
10. Consoli SM, Rolhion S, Martin C et al. (2006) Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology 212: 128-136
11. Evers AWM, Lu Y, Duller P et al. (2006) Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 152: 1275-1281
12. Farber EM, Nall L (1974) The natural history of psoriasis in 5600 patients. Dermatologica 148: 1-18
13. Fortune DG, Richards HL, Griffiths CEM (2005) Psychological factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 23: 681-685
14. Fortune DG, Richards HL, Griffiths CEM, Main CJ (2004) Targeting cognitive-behavioral therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 43, 65-82
15. Fortune DG, Richards HL, Kirby B et al. (2002) A cognitive-behavioral symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 146: 458-465
16. Fortune DG, Richards HL, Kirby B et al. (2003) Psychological distress impairs clearance in patients treated with photochemotherapy. Arch Derm 139: 752-756
17. Frederiksson T, Pettersson U (1978) Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157: 238-244
18. Fritsch P (2004) Dermatologie Venerologie, 2 Aufl. Springer, Berlin Heidelberg New York Tokyo
19. Gudjonsson JE, Karason A, Antonsdottir AA et al. (2002) HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 118: 362-365
20. Gupta MA, Gupta AK (1998) Depression and suicidal ideation in dermatological patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 139: 846-850
21. Hahn M, Schulz T (2005) Gesundheitsökonomische Aspekte der Psoriasistherapie. Hautarzt 56: 576-580
22. Ho VC (2004) The use of ciclosporin in psoriasis: a clinical review. Br J Dermatol [Suppl 67]: 150: 1-110
23. Krueger G, Duvic M (1994) Epidemiology of psoriasis: clinical issues. J Invest Dermatol 102: 14-18
24. Kuhl J (2000) The volitional basis of personality systems interaction theory: Applications in learning and treatment contexts. International Journal of Educational Research 33: 665-703
25. Kuhl J (2001) Motivation und Persönlichkeit Interaktionen psychischer Systeme. Hogrefe, Göttingen
26. Kuhl J, Henseler W (2004) Entwicklungsorientiertes Scanning (EOS). In: Rosenstiel L (Hrsg) Handbuch der Kompetenzmessung. Schäffer-Poeschel, Heidelberg, S 428-453
27. Kuhl J, Kaschel R (2004) Entfremdung als Krankheitsursache: Selbstregulation von Affekten und Integrative Kompetenz. Psychologische Rundschau 55: 61-71
28. Lee E, Koo J, Berger T (2005) UVB phototherapy and skin cancer risk: a new review of the literature. Int J Dermatol 44: 355-360
29. Lombardo BA, Cave LA, Naso S (1988) Use of a support group for dermatological patients. Cutis 41: 121-124
30. Moll I (2006) Dermatologie und Venereologie. Thieme, Stuttgart
31. Morris A, Rogers M, Fischer G, Williams K (2001) Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 18: 188-198
32. Owen CM, Chalmers RJ, O'Sullivan T, Griffiths CEM (2001) A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 145: 886-890
33. Petermann F (1997) Patientenschulung und Patientenberatung, 2. vollständ. überarbeitete Aufl. Hogrefe, Göttingen
34. Poikolainen K, Reunala I, Karvonen J (1994) Smoking, alcohol, and life events related to psoriasis among women. Br J Dermatol 130: 473-477
35. Poikolainen K, Reunala T, Karvonen J (1990) Alcohol intake: a risk factor for psoriasis in young and middle-aged men? BMJ 28: 780-788
36. Richards H, Fortune D (2006) Psychological distress and adherence in patients with psoriasis. J Eur Acad Dermatol Venereol 20: 33-41
37. Schäfer T (2006) Epidemiology of psoriasis - review and the German perspective. Dermatology 212: 327-337
38. Schmitt J, Wozel G (2005) The Psoriasis Area and Severity Index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 210: 194-199
39. Sommer DM, Jenisch S, Suchan M et al. (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298: 321-328
40. Travis L, Weinberg JM (2002) Medical backgrounder: psoriasis. Drugs Today 38: 847-865
41. Warschburger P, Buchholz HT, Petermann F (2004) Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? Br J Dermatol 150: 104-111
42. Werfel T, Breitbart E, Kleinheinz A et al. (2006) Psoriasisschulung für erwachsene Patienten nach den Regeln der Arbeitsgemeinschaft Dermatologische Prävention. Hautarzt 57: 913-915
43. Yones SS, Palmer RA, Garibaldinos TT, Hawk JL (2006) Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. Arch Dermatol 142: 836-842